Presentation is loading. Please wait.

Presentation is loading. Please wait.

MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin.

Published byThomas Kjær Modified over 6 years ago

Similar presentations

Presentation on theme: "MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin."— Presentation transcript:

1 MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin Li, PhD, Zhen Bian, Zhiyuan Lv, PhD, Lei Shi, MSc, Jing Zhang, MSc, Donghai Li, Hongwei Gu, PhD, Chen-Yu Zhang, MD, PhD, Yuan Liu, MD, PhD, Ke Zen, PhD  Journal of Allergy and Clinical Immunology  Volume 132, Issue 2, Pages e8 (August 2013) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Downregulation of expression levels of miR-17, miR-20a, and miR-106a in promyelocytic cells during SIRPα protein induction by cell differentiation agents. A-C, Induction of SIRPα protein but not SIRPα mRNA by TPA (30 nmol/L) in promyelocytic HL-60 and U937 cells. Note that the SIRPα protein level (Fig 1, A, upper panel, and B) was significantly increased by TPA, whereas the SIRPα mRNA level (Fig 1, A, lower panel, and C) was not altered. D, Microarray analysis of changes in miRNA expression in TPA-differentiated HL-60 cells. E, TaqMan probe–based quantitative RT-PCR validation of differentially expressed miRNAs. F and G, Inverse correlation between SIRPα protein levels (Fig 1, F) and levels of miR-17/20a/106a (Fig 1, G) in HL-60 cells during RA-induced differentiation process. Data represent means ± SDs of 3 independent experiments performed in triplicate. ∗P < .05 and ∗∗P < .01. ND, Undetectable. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Identification of SIRPα as a common target of miR-17, miR-20a, and miR-106a. A, Bioinformatics analysis prediction of the possible target sites of miR-17/20a/106a in the 3′ UTR of SIRPα. B, Validation of binding of miR-17, miR-20a, and miR-106a with the 3′ UTR of SIRPα by using a luciferase reporter assay. Mut, Mutated SIRPα 3′ UTR; WT, wild type SIRPα 3′ UTR. C and D, Levels of SIRPα protein (Fig 2, C) and mRNA (Fig 2, D) in THP-1 cells transfected with pre–miR-17, pre–miR-20a, or pre–miR-106a. E-G, Levels of miRNAs (miR-17, miR-20a, and miR-106a; Fig 2, E), SIRPα protein (Fig 2, F), and SIRPα mRNA (Fig 2, G) in THP-1 after transfection with scrambled or miRNA ASOs. Data represent means ± SDs of 3 independent experiments. ∗P < .05 and ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Regulation of SIRPα protein expression by miR-17, miR-20a, and miR-106a. A and B, Effect of overexpression of miR-17 on TPA-induced SIRPα protein production in HL-60 cells. Note that forced expression of pre–miR-17 significantly increases miR-17 levels (Fig 3, A) but abolishes SIRPα induction by TPA (Fig 3, B). C and D, Effect of depleting miR-17, miR-20a, and miR-106a on SIRPα protein levels in HL-60 cells. Note that compared with scrambled oligonucleotides, the combined miRNA ASOs, particularly miRNA inhibitors (the combination of 3 miRNA ASOs) in HL-60 cells, strongly decrease levels of the 3 miRNAs (Fig 3, C) and lead to SIRPα induction, even in the absence of differentiation reagents (Fig 3, D). E, Localization of SIRPα induced by depletion of miR-17, miR-20a, and miR-106a in HL-60 cells. Scale bar = 2 μm. Data represent means ± SDs of 3 independent experiments. ∗P < .05 and ∗∗P < .01. ND, Undetectable. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Downregulation of miR-17, miR-20a, and miR-106a in HL-60 cells by TPA or RA through suppression of the c-Myc signaling pathway. A and B, Reduction of c-Myc expression in HL-60 cells by TPA (Fig 4, A) and RA (Fig 4, B) treatment. C, Overexpression of c-Myc inhibits RA-mediated downregulation of miR-17, miR-20a, and miR-106a in HL-60 cells. D and E, Overexpression of c-Myc in RA-treated HL-60 cells reverses RA-induced SIRPα protein production. Data represent means ± SDs of 3 independent experiments. ∗P < .05 and ∗∗P < .01. ND, Not determined. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Effect of miR-17, miR-20a, and miR-106a on LPS-induced downregulation of SIRPα in murine alveolar macrophages. A and B, LPS stimulation (100 ng/mL) significantly reduces SIRPα protein levels (Fig 5, A) but increases miR-17, miR-20a, and miR-106a levels (Fig 5, B) in macrophages. C and D, Overexpression of miR-17 in macrophages (Fig 5, C) decreases SIRPα protein levels (Fig 5, D). E and F, Effect of depleting miR-17, miR-20a, and miR-106a on LPS-induced SIRPα reduction in mouse alveolar macrophages. Note that transfection with the miRNA inhibitors strongly reverses both LPS-induced miR-17/20a/106a increase (Fig 5, E) and SIRPα reduction (Fig 5, F) in macrophages. Data represent means ± SDs of 3 independent experiments. ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig 6 Role of miR-17, miR-20a, and miR-106a in modulating inflammatory responses of mouse alveolar macrophages. A and B, Phagocytic activity of macrophages detected by means of flow cytometry. Macrophages were transfected with or without scrambled oligonucleotides or combined miRNA inhibitors. Cells were then incubated with fluorescently labeled zymosan particles at 37°C in the presence or absence of 100 ng/mL LPS. C-E, secretion of TNF-α (Fig 6, C), IL-6 (Fig 6, D), and NO (Fig 6, E) by macrophages. Data represent means ± SDs of 3 independent experiments. ∗P < .05 and ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Fig 7 Modulation of mouse macrophage inflammatory responses by depletion of miR-17, miR-20a, and miR-106a in thioglycollate-elicited peritoneal macrophages. A, Specific downregulation of miR-17, miR-20a, and miR-106a in peritoneal macrophages by PEI/miRNA inhibitors. B and C, Increased SIRPα protein levels in peritoneal macrophages by means of depletion of miR-17, miR-20a, and miR-106a. D, Reduced phagocytic activity of peritoneal macrophages with miR-17, miR-20a, and miR-106a depletion. E and F, Decreased Matrigel invasion (Fig 7, E) and migration across Transwell filters (Fig 7, F) of peritoneal macrophages on depletion of miR-17, miR-20a, and miR-106a. Data represent means ± SDs of 3 independent experiments. ∗P < .05 and ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Fig E1 Disparity between SIRPα protein levels and SIRPα mRNA levels in various cell types (A) and tissue (B). Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Fig E2 Increased miR-17, miR-20a, or miR-106a levels in THP-1 cells by means of overexpression with pre–miR-17 (A), pre–miR-20a (B), or pre–miR-106a (C) oligonucleotide. Data represent means ± SDs of 3 independent experiments. ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

11 Fig E3 Inhibition of TPA-induced SIRPα protein production in HL-60 cells by overexpression of miR-20a (A) or miR-106a (B). CTL, Control; ND, undetectable. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

12 Fig E4 Levels of miRNAs (A) and SIRPα protein (B) in TPA-treated HL-60 cells with or without transfection of miRNA inhibitors. Note that although miRNA inhibitors bring some additional decrease in miR-17, miR-20a, and miR-106a levels in TPA-treated HL-60 cells, they do not further increase SIRPα protein levels. Data represent means ± SDs of 3 independent experiments. ND, Undetectable. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

13 Fig E5 Blockade of RA-induced reduction of c-Myc levels in HL-60 cells by overexpressing c-Myc. Data represent means ± SDs of 3 independent experiments. ∗∗P < .01. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

14 Fig E6 Relatively higher miR-17, miR-20a, and miR-106 levels in SIRPα-negative human epithelial HT29 cells and liver carcinoma HepG2 cells than in SIRPα-positive THP-1 cells. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin."

Similar presentations

Volume 342, Issue 1, Pages (January 2014)

Volume 342, Issue 1, Pages (January 2014)
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages  Min Zhang, Jian-Feng Wu, Wu-Jun Chen,

MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages  Min Zhang, Jian-Feng Wu, Wu-Jun Chen,
Doina M. Racila, MD, Joel N. Kline, MD, MSc 

Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Cell Physiol Biochem 2017;44:1867– DOI: /

Cell Physiol Biochem 2017;44:1867– DOI: /
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,

MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions  Asako Ichihara, MD, PhD, Zhongzhi Wang, PhD, Masatoshi Jinnin,

Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions  Asako Ichihara, MD, PhD, Zhongzhi Wang, PhD, Masatoshi Jinnin,
MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis  Ankit Srivastava, MTech, Pernilla Nikamo, PhD,

MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis  Ankit Srivastava, MTech, Pernilla Nikamo, PhD,
Volume 144, Issue 3, Pages e4 (March 2013)

Volume 144, Issue 3, Pages e4 (March 2013)
Long Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma  Kewei Ren, Yahua Li,

Long Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma  Kewei Ren, Yahua Li,
MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells  Mi Zhang, MD, Xiaohong Liu, MD, Xiwu Zhang, MD, Zhigang Song, MD, Lin Han,

MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells  Mi Zhang, MD, Xiaohong Liu, MD, Xiwu Zhang, MD, Zhigang Song, MD, Lin Han,
Pharmacological inhibition of caspase-8 suppresses inflammation-induced lymphangiogenesis and allograft rejection in the cornea  Wenru Su, MD, PhD, Longhui.

Pharmacological inhibition of caspase-8 suppresses inflammation-induced lymphangiogenesis and allograft rejection in the cornea  Wenru Su, MD, PhD, Longhui.
Modulation by aspirin of nuclear phospho–signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated.

Modulation by aspirin of nuclear phospho–signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated.
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.

Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Let-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation  Manish Kumar, MSc, Tanveer Ahmad, MSc, Amit Sharma, PhD, Ulaganathan Mabalirajan,

Let-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation  Manish Kumar, MSc, Tanveer Ahmad, MSc, Amit Sharma, PhD, Ulaganathan Mabalirajan,
Volume 135, Issue 5, Pages e24 (November 2008)

Volume 135, Issue 5, Pages e24 (November 2008)
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,

MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte–associated.

MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte–associated.
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,

Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H

Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H

Similar presentations

Ads by Google